Biogen stock jumped Wednesday after the FDA gave its Eisai-partnered Alzheimer’s treatment a fast track designation.
The post Biogen Stock Continues Its 24% Sprint On A Twist In Alzheimer’s Treatment appeared first on Investor’s Business Daily.
Biogen stock jumped Wednesday after the FDA gave its Eisai-partnered Alzheimer’s treatment a fast track designation.
The post Biogen Stock Continues Its 24% Sprint On A Twist In Alzheimer’s Treatment appeared first on Investor’s Business Daily.
Biogen stock jumped Wednesday after the FDA gave its Eisai-partnered Alzheimer’s treatment a fast track designation.
The post Biogen Stock Continues Its 24% Sprint On A Twist In Alzheimer’s Treatment appeared first on Investor’s Business Daily. Read MoreTechnology, All News And Stock Ideas, Biotech And Pharma Stock News, Snap Stories Technology – Investor’s Business Daily
